Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Astrocytosis

3,4-dihydroxyphenylacetic acid has been researched along with Astrocytosis in 6 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
"The psychostimulant methamphetamine (MA) is toxic to nigro-striatal dopaminergic terminals in both experimental animals and humans."1.32Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity. ( Battaglia, G; Busceti, CL; De Blasi, A; Fornai, F; Lembo, G; Nicoletti, F, 2003)
"Reactive gliosis occurred only in response to combined PQ + MB in dorsal-medial but not ventral striatum."1.31The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. ( Baggs, RB; Cory-Slechta, DA; Richfield, EK; Tank, AW; Thiruchelvam, M, 2000)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuroiwa, H1
Yokoyama, H2
Kimoto, H1
Kato, H2
Araki, T2
McCormack, AL1
Thiruchelvam, M2
Manning-Bog, AB1
Thiffault, C1
Langston, JW1
Cory-Slechta, DA2
Di Monte, DA1
Battaglia, G1
Fornai, F1
Busceti, CL1
Lembo, G1
Nicoletti, F1
De Blasi, A1
Takagi, S1
Watanabe, Y1
Takeda, A1
Sawashita, J1
Takefuta, S1
Okada, S1
Richfield, EK1
Baggs, RB1
Tank, AW1

Other Studies

6 other studies available for 3,4-dihydroxyphenylacetic acid and Astrocytosis

ArticleYear
Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease.
    Metabolic brain disease, 2010, Volume: 25, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; C

2010
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
    Neurobiology of disease, 2002, Volume: 10, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Environm

2002
Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity.
    Journal of neurochemistry, 2003, Volume: 86, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-1 Rec

2003
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Cytoprotectio

2008
Distribution of zinc in the substantia nigra of rats treated with 6-hydroxydopamine.
    Biological trace element research, 1998, Volume: 61, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Autoradiography; Blood-Brain Barrier; Ch

1998
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Dec-15, Volume: 20, Issue:24

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Carrier Proteins; Cell Count; Corpus Striatum;

2000